Artelo Biosciences to Present at the Virtual Fall Investor Summit on November 18th
LA JOLLA, CA / ACCESSWIRE / November 11, 2020 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company developing...
Month: November 2020
Elite Pharmaceuticals, Inc. To Host Conference Call To Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2021 Results on November 17, 2020
Financials for Second Quarter of Fiscal Year 2021 ended September 30, 2020 will be released November 16, 2020 NORTHVALE, NJ...
Aytu BioScience to Present at the Jefferies 2020 Virtual London Healthcare Conference Wednesday, November 18 at 1:45pm ET
ENGLEWOOD, CO / ACCESSWIRE / November 11, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused...
Planet 13 Announces Release Date of Third Quarter 2020 Financial Results
LAS VEGAS, NV / ACCESSWIRE / November 11, 2020 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) ("Planet 13" or the "Company"),...
NanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19
SHELTON, CT / ACCESSWIRE / November 11, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the...
How To Prepare For Your Medical Mission
If you’re a medical professional and you’ve committed to serving on a medical mission, then congratulations! You’ll be making a...
Chiesi USA, Inc. Earns Fourth Consecutive Corporate Philanthropy Award by Triangle Business Journal
Chiesi in the Community’s 2019 efforts total more than $980,000 and 2,400 volunteer hours for patient and community partners CARY,...
Mersana Therapeutics Reports Preclinical Data from Immunosynthen STING-Agonist ADC Platform and Pipeline
Immunosynthen ADCs activate the STING pathway in both tumor-resident immune cells and in the tumor cells, resulting in robust anti-tumor...
Cerner Simplifies Patient Communication
New capabilities will unify and automate previously disjointed communications, enhance patient engagement, and save clinicians time KANSAS CITY, Mo., Nov....
Precipio Announces Q3-2020 Shareholder Update Call
Conference Call to be held on Thursday, November 19th, 2020 at 5:00 PM EST NEW HAVEN, Conn., Nov. 11, 2020...
Sorrento Announces IND Filing for COVI-DROPS, an Intranasal Formulation of a High Potency Neutralizing Antibody Against SARS-CoV-2
IND filing today for STI-2099 (COVI-DROPS™) for a phase 1 safety and pharmacokinetic study in healthy volunteers and outpatients with...
SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020
Late breaking poster demonstrates SO-C101 was well tolerated to date with no dose-limiting toxicities Confirmed partial response was observed after...
BioDelivery Sciences to Present Virtually and Host 1×1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company...
Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
WARREN, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
IntelGenx Announces Issuance of U.S. Patent for Novel Technology Applicable to Cannabis-Containing Oral Films
SAINT LAURENT, Quebec, Nov. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leading oral drug delivery company,...
MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy
Registry to Enable Prospective Safety Study “DISCOVER-HCM” to Track Long-Term Safety and Effectiveness of Mavacamten in Patients with Symptomatic, Obstructive...
Better Choice Company to Host Third Quarter 2020 Financial Results Call on November 18 at 8:30 a.m. ET
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness...
New Therapeutic Protocols Targeting Debilitating Disorders on the Horizon
NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) today announces its placement in...
Enlivex to Present Schedule for Sepsis, COVID-19 and Solid Cancer Programs at H.C. Wainwright’s 6th Annual Israel Conference
Nes Ziona, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company,...
Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
SEATTLE, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...